{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:17:22Z","timestamp":1791163042582,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.humpath.2005.12.016","type":"journal-article","created":{"date-parts":[[2006,6,12]],"date-time":"2006-06-12T12:47:53Z","timestamp":1150116473000},"page":"562-568","source":"Crossref","is-referenced-by-count":26,"title":["The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Ana Sofia","family":"Rocha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Risberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Trovisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas Vieira","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Lazarovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Sobrinho-Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2005.12.016_bib1","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1038\/sj.onc.1206706","article-title":"BRAF mutations and RET\/PTC rearrangements are alternative events in the etiopathogenesis of PTC","volume":"22","author":"Soares","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2005.12.016_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1385\/EP:13:4:271","article-title":"Molecular pathobiology of thyroid neoplasms","volume":"13","author":"Tallini","year":"2002","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2005.12.016_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00018-003-3099-3","article-title":"Neurotrophins and their receptors: signaling trios in complex biological systems","volume":"61","author":"Teng","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.humpath.2005.12.016_bib4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2005.12.016_bib5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI200522758","article-title":"The RET\/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells","volume":"115","author":"Melillo","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humpath.2005.12.016_bib6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/PL00000919","article-title":"Neurotrophin signalling pathways regulating neuronal apoptosis","volume":"58","author":"Miller","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.humpath.2005.12.016_bib7","first-page":"3749","article-title":"The neurotrophin receptor p75NTR is a tumor suppressor in human prostate cancer","volume":"21","author":"Krygier","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2005.12.016_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.10160","article-title":"Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor\u2013mediated metastasis of human prostate cancer cells","volume":"98","author":"Krygier","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2005.12.016_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/B:BREA.0000010704.17479.8a","article-title":"Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma","volume":"83","author":"Davidson","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.humpath.2005.12.016_bib10","first-page":"4337","article-title":"Expression of nerve growth factor receptors and their prognostic value in human breast cancer","volume":"61","author":"Descamps","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2005.12.016_bib11","first-page":"3457","article-title":"Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients","volume":"7","author":"Davidson","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2005.12.016_bib12","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1038\/sj.onc.1203922","article-title":"The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium","volume":"19","author":"Russell","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2005.12.016_bib13","series-title":"Atlas of tumor pathology","author":"Rosai","year":"1993"},{"key":"10.1016\/j.humpath.2005.12.016_bib14","series-title":"WHO classification of tumours, World Health Organization classification of tumors","article-title":"Pathology and genetics. Tumours of endocrine organs","author":"DeLellis","year":"2004"},{"key":"10.1016\/j.humpath.2005.12.016_bib15","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/jnci\/82.23.1821","article-title":"Monoclonal antibodies to immunogenic lymphoma cell variants displaying impaired neoplastic properties: characterization and applications","volume":"82","author":"Hochman","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2005.12.016_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/path.1511","article-title":"BRAF mutations are associated with some histological types of papillary thyroid carcinoma","volume":"202","author":"Trovisco","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2005.12.016_bib17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/1097-0215(20000915)87:6<763::AID-IJC1>3.0.CO;2-T","article-title":"Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas","volume":"87","author":"Fluge","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2005.12.016_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbagen.2004.04.016","article-title":"Expression of erbB receptors mRNA in thyroid tissues","volume":"1673","author":"Kato","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2005.12.016_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.847","article-title":"Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis","volume":"94","author":"Ruco","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2005.12.016_bib20","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1038\/sj.onc.1201083","article-title":"Activated ras and ret oncogenes induce overexpression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells","volume":"14","author":"Ivan","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2005.12.016_bib21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/hupa.2001.27602","article-title":"Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues","volume":"32","author":"Fanburg-Smith","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2005.12.016_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/EP:13:1:03","article-title":"RET\/PTC rearrangement in thyroid tumors","volume":"13","author":"Nikiforov","year":"2002","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2005.12.016_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/106689690501300301","article-title":"A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation","volume":"13","author":"Castro","year":"2005","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2005.12.016_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00428-005-1236-0","article-title":"Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness","volume":"446","author":"Trovisco","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2005.12.016_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0303-7207(00)00286-0","article-title":"Nerve growth factor and retinoic acid inhibit proliferation and invasion in thyroid tumor cells","volume":"167","author":"Paez","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.humpath.2005.12.016_bib26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2005.12.016_bib27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00000372-200108000-00002","article-title":"The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly expressed in spindled melanomas","volume":"23","author":"Iwamoto","year":"2001","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2005.12.016_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/path.861","article-title":"Expression of neurotrophins and their receptors in pigment cell lesions of the skin","volume":"194","author":"Innominato","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2005.12.016_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1097-0215(19990702)82:1<112::AID-IJC19>3.0.CO;2-9","article-title":"Correlation of overexpression of the low-affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells","volume":"82","author":"Walch","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2005.12.016_bib30","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1091\/mbc.4.11.1205","article-title":"Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA","volume":"4","author":"Herrmann","year":"1993","journal-title":"Mol Biol Cell"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817706000074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817706000074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T05:23:49Z","timestamp":1555651429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817706000074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0046817706000074"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2005.12.016","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}